Barcelona BioMed Workshop

Building Bridges in your Network (IV): Luc Marti, COO at Cebiotex

8 Nov 2017

Building Bridges in your Network (IV): Luc Marti, COO at Cebiotex

The next session of Building Bridges in Your Network is on 8 November 2017!

The Innovation Department invites you to meet & greet our next speaker in the series, Dr. Luc Marti, Chief Operating Officer (COO) at Cebiotex. Dr. Marti will bring an overview on his experience in the biotech environment and how this relates to the value chain of the drug development process.

Sessions are open to all IRB members. However, please note that only 10 places are available. In addition, a number of places are reserved for IRB Barcelona alumni.

If you wish to participate, please register before 26 October (Registration Form). Alumni members please contact us at innovation@irbbarcelona.org. A confirmation email will be sent after the registration deadline.

 

Organizer: IRB Innovation Department
Speaker: Luc Marti, COO at Cebiotex
Date: Wednesday, 8 November 2017, 16:00-17:00
Place: IRB Meeting Room 1 – IRB Administration Building 1st Floor
Language: English
Audience: Open to the entire IRB Barcelona community (max. 10 people)

 

 

Building Bridges in Your Network is a meet & greet programme set up by the Innovation Department. It aims to provide you with the opportunity to meet key professionals in the bio sector and to expand and/or consolidate your network.

 

Cebiotex, based at the PCB, develops a nanofiber-based drug delivery system for cancer indication and is starting new project using the same in house technology via electrospun nanofiber technology.

 

Luc Marti, currently Chief Operating Officer (COO) at Cebiotex and previously Vice President of R&D Operations at Artax Biopharma (MA, US), cofounded Genmedica Therapeutics in 2005—a company partially bought out by the Ferrer group in 2013. His role is to coordinate R&D to bring new drugs for a variety of conditions, including diabetes, autoimmune diseases and cancer, from the discovery stage to clinical trials. The three biotechs he directly collaborated with have raised more than US $30 M in venture capital. He is also a consultant for various companies in the Barcelona area. Luc holds a PhD in Pharmacology (Toulouse, 1998) and an online MBA with specialisation in biotechnology from the IE business school (2010).

Cebiotex, based at the PCB, develops a nanofiber-based drug delivery system for cancer indication and is starting new project using the same in house technology via electrospun nanofiber technology.